Volume-value gap to narrow from Q3
The ~220bps gap between volume growth (3.6%) and value growth (1.4%) should narrow from Q3 onwards as promotional intensity base normalizes and last year's extra gramage/price cuts lap.
JYOTHYLAB / guidance tracker
Keep management guidance in view.
Jyothy Labs · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
growth
Full-year EBITDA margin 16-17%
Management maintained full-year EBITDA margin guidance at 16-17%, expecting H2 improvement as demand recovers but not sufficient to fully offset H1 pressures.
Household insecticides turnaround by FY27
Company targets to turn household insecticides profitable by second half of FY27 through new product launches (aerosols, rackets), price increases in coils, and ongoing cost optimization.
Marketing spend at 8-9% of revenue
A&P spend moderated to 7.8% in Q1 but commitment to annual brand investment remains intact at 8-9% of revenue, continuing in near term.
FY27 Double-Digit Revenue Growth (ex-PR)
Management targets double-digit revenue growth for FY27 excluding the discontinued Pril and Fa brands. Approximately 3-4% price increase will contribute to growth along with high single-digit volume growth expected through the year.
H2 FY27 Expected Substantially Better than H1
Both growth and profitability expected to be substantially better in H2 FY27 compared to H1, subject to demand momentum and commodity price stability. Margin recovery anticipated to be gradual and progressive.
Historical Margin Levels Recovery Goal
Management's stated goal is to return to historical EBITDA margin levels, though acknowledges a large portion of margin recovery is linked to crude oil price movements and external conditions.
Step Up A&P Investments
A&P spends were moderated to 6.5% of revenue (vs 7.8% YoY) due to input cost inflation. Management intends to step up investments in advertising and brand building to support long-term sustainable growth from Q1 FY27 onwards.
Double-digit volume growth target by FY26 exit
Management aims to achieve double-digit volume and value growth by end of FY26, targeting similar value and volume growth with expected 2-2.5% gap favoring volume. October sales signals are positive supporting this aspiration.
EBITDA margin guidance of 16-17% for H2 FY26
Assuming commodity prices remain stable and demand improves, EBITDA margin is expected to remain in the 16-17% range during second half, with personal care margins expected to recover to double-digits in a couple of quarters.
HI segment turnaround in 4-6 quarters
Household insecticides segment focused on profitability improvement with liquid vaporizer already surpassing coils. New products (maxi aerosols, anti-mosquito rackets) showing early traction. Category expected to turn profitable in 4-6 quarters.
Working capital normalization to 18-20 days
Net working capital currently at 22 days (vs 19 days in March) due to higher share from modern trade/e-commerce/quick commerce. Expected to normalize to 18-20 days in medium-term as channel mix stabilizes.
Margin pressure to persist for minimum 2 quarters
Gross margins likely to remain subdued due to MRP cuts in Dishwash and liquid detergent, elevated input costs (LABSA/SLEES), geopolitical volatility, and forex fluctuations.
A&P spend to remain in 8-9% range over broader horizon
Current quarter A&P at 7.7% of revenue, but longer-term guidance maintained at 8-9% range.
HI segment turnaround by FY27 end
Management targets profitable HI segment by end of FY27, with coil dependence reduced and LV/NPD portfolio driving double-digit growth.
Direct reach expansion to 14 lakh outlets
Company is on track to reach 14 lakh directly serviced retail outlets by year-end, adding 1 lakh outlets pan-India.